Relation between dose of FE 999049, a recombinant FSH derived from a human cell-line, used for controlled ovarian stimulation and number of oocytes, embryos and blastocysts

被引：0

作者：

Arce, J. C. ^{[1
]}

Nyboe Andersen, A. ^{[2
]}

Fernandez-Sanchez, M. ^{[3
]}

Visnova, H. ^{[4
]}

Bosch, E. ^{[5
]}

Garcia-Velasco, J. A. ^{[6
]}

Barri, P. ^{[7
]}

de Sutter, P. ^{[8
]}

Klein, B. M. ^{[9
]}

Fauser, B. C. J. M. ^{[10
]}

机构：

[1] Ferring Pharmaceut, Global Clin R&D Reprod Hlth, Copenhagen, Denmark

[2] Copenhagen Univ Hosp, Fertil Clin, Copenhagen, Denmark

[3] IVI Sevilla, Reprod Endocrinol, Seville, Spain

[4] IVF Cube, Fertil Clin, Prague, Czech Republic

[5] IVI Valencia, Reprod Endocrinol, Valencia, Spain

[6] IVI Madrid, Reprod Endocrinol, Madrid, Spain

[7] IU Dexeus, Gynaecol & Obstet, Barcelona, Spain

[8] UZ Gent, Reprod Med, Ghent, Belgium

[9] Ferring Pharmaceut, Global Clin R&D Biometr, Copenhagen, Denmark

[10] UMC Utrecht, Div Women & Baby, Utrecht, Netherlands

来源：

HUMAN REPRODUCTION | 2014年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-492

引用

页码：322 / 323

页数：2

共 13 条

[1] The influence of patient-specific variables and dose-response modelling in controlled ovarian stimulation with FE 999049, a human recombinant FSH derived from a human cell-line
Roshammar, D.
Klein, B. M.
Arce, J. C.
HUMAN REPRODUCTION, 2014, 29 : 323 - 323
[2] The contribution of FSH receptor polymorphism on ovarian response and treatment efficiency following stimulation with FE 999049, a recombinant FSH from a human cell-line
Arce, J. C.
HUMAN REPRODUCTION, 2015, 30 : 438 - 438
[3] DOSE-RESPONSE ENDOCRINE PROFILES FOR A NOVEL RECOMBINANT FSH PREPARATION (FE 999049) DERIVED FROM A HUMAN CELL-LINE
Andersen, A. Nyboe
Barri, P.
Garcia-Velasco, J. A.
De Sutter, P.
Bosch, E.
Arce, J. -C.
FERTILITY AND STERILITY, 2013, 100 (03) : S18 - S18
[4] Different pharmacokinetic properties between a novel recombinant FSH (FE 999049) derived from a human cell line and follitropin alfa
Sandstrom, R.
Olsson, H.
Grundemar, L.
HUMAN REPRODUCTION, 2013, 28 : 352 - 352
[5] Impact of body weight of IVF/ICSI patients on the pharmacokinetics and pharmacodynamic responses to FE 999049, a recombinant FSH derived from a human cell-line
Klein, B. M.
Arce, J. C.
HUMAN REPRODUCTION, 2014, 29 : 323 - 323
[6] A RANDOMIZED, ASSESSOR-BLIND, DOSE-RESPONSE TRIAL IN PATIENTS UNDERGOING CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI WITH A NOVEL RECOMBINANT FSH PREPARATION (FE 999049) DERIVED FROM A HUMAN CELL-LINE.
Arce, J. -C.
Andersen, A. Nyboe
Fernandez-Sanchez, M.
Bosch, E.
Visnova, H.
Fauser, B. J. C. M.
FERTILITY AND STERILITY, 2013, 100 (03) : S59 - S59
[7] A randomised, double-blind, active-controlled, multiple-dose trial investigating the pharmacokinetics and pharmacodynamics of a novel recombinant FSH (FE 999049) derived from a human cell line
Olsson, H.
Sandstrom, R.
Grundemar, L.
HUMAN REPRODUCTION, 2013, 28 : 351 - 351
[8] A randomised, assessor-blind, dose-response trial in patients undergoing COS for IVF/ICSI with a novel recombinant FSH (FE 999049) derived from a human cell line
Andersen, A. Nyboe
Fernandez-Sanchez, M.
Bosch, E.
Visnova, H.
Barri, P.
Garcia-Velasco, J. A.
De Sutter, P.
Fauser, B. J. C. M.
Arce, J. C.
HUMAN REPRODUCTION, 2013, 28 : 351 - 352
[9] Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
Olsson, Hakan
Sandstrom, Rikard
Bagger, Yu
CLINICAL DRUG INVESTIGATION, 2015, 35 (04) : 247 - 253
[10] Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
Håkan Olsson
Rikard Sandström
Yu Bagger
Clinical Drug Investigation, 2015, 35 : 247 - 253

← 1 2 →